Impact of Microplastic Contaminants on Drug Stability and Safety

Microplastics have emerged as an environmental contaminant of global concern. While most research has focused on the impact of microplastics on aquatic ecosystems and human health via ingestion, an underexplored area is their potential interference with pharmaceutical products. This study investigates how microplastic contaminants may alter the stability and safety of drug formulations. By examining existing literature, experimental methodologies, and survey data from pharmaceutical quality assurance professionals, we analyze the possible mechanisms through which microplastics interact with drug compounds, leading to degradation, altered bioavailability, or potential toxicological effects. The findings indicate that microplastics, owing to their physicochemical properties and ability to adsorb contaminants, can adversely affect drug stability during storage and administration. The implications of these interactions are discussed, emphasizing the need for stricter quality control measures in drug production and storage environments. Finally, recommendations for future research directions are provided to address the gaps in knowledge regarding microplastic contamination in pharmaceutical contexts.